Sleuth

Sleuth · Launch Video Breakdown: Hook, Pacing & Motion Design

Sleuth helps biopharma teams get to conviction faster, turning complex strategic questions into clear, evidence-backed answers in hours instead of months.

0:00 · The Hook · Biopharma Decisions and Blind Spots
0:00 / 0:00
AI AgentsProductionApril 21, 2026

Direct Problem Agitation

6.1

Cuts / min

1:38

Runtime

451K

Views

259

Likes

61

Reposts

166

Replies

Scene-by-scene timeline & spoken transcript

  1. The Hook

    Biopharma Decisions and Blind Spots

    “Biopharma's toughest decisions are being made with blind spots. Billion-dollar acquisitions, pipeline bets that define a company for a decade, and no one has the complete picture. We built Sleuth to change that.”

    On screen
    Biopharma's toughest decisions Are being made With blind spots. Billion-dollar acquisitions. Pipeline bets that define a company for a decade. And no one has the complete picture. We built Sleuth to change that.
    Camera
    Static medium shot with slight digital punch-in
    Motion
    Direct-to-camera presenter with clean animated lower-third subtitles
  2. Product Reveal

    Prompt to Landscape Table

    “Let's say your team is evaluating a new therapeutic opportunity. Within minutes, Sleuth will build a structured view of the entire space. Every relevant program, mechanism, and competitor, including the assets that most databases miss entirely.”

    On screen
    Welcome to Sleuth Studio Map competitive landscapes, evaluate assets, prioritize indications, and more. Next-Gen Bispecific Antibody Landscape
    Camera
    Screen capture viewport panning and zooming into tabular data rows
    Motion
    Simulated UI interaction with sliding sidebar metadata detail view
  3. Feature Teaser

    Benchmarking, Deal Matrix, and Auto-Decks

    “We can go deeper. Benchmark clinical data head to head. Map the deal landscape. Assess every indication for fit. Layer in your own internal data and Sleuth will connect it all. Every analysis will build on the last. And when you're ready, Sleuth produces the deliverables your team needs — memos, slides, benchmarks, in your format and fully customizable.”

    On screen
    Clinical Benchmarking: NSCLC Bispecifics Deal Landscape: Solid-Tumor Bispecific Partnerships Indication Prioritization Matrix Strategic Assessment Deck Key Insights & Recommendations
    Camera
    Smooth crossfades and focused zooms across distinct UI modules
    Motion
    Card stacking, bubble matrix plot transitions, and slide preview generation
  4. Problem Agitation

    Proprietary Data Connections

    “Sleuth sees the connections between targets, mechanisms, trials, and deals that don't exist in any single database — because we build and maintain them.”

    On screen
    Sleuth sees the connections between targets, mechanisms, trials, and deals that don't exist in any single database — because we build and maintain them.
    Camera
    Static centered medium framing
    Motion
    Direct founder address highlighting competitive moat
  5. Feature Teaser

    Real-time Synthesis and Continuous Updates

    “Sleuth will surface patterns you wouldn't find on your own. The kind of insight that used to take a six-week consulting engagement — if you found it at all. And come back in a month. Everything's updated. New trials, new deals, new data. Every analysis you built is still current.”

    On screen
    $55B+ in bispecific deal capital is concentrated in NSCLC — the highest-opportunity indications remain underinvested Key Insight Surfaced
    Camera
    Full dashboard view transitioning into highlighted notification badges
    Motion
    Banner reveal animation and dynamic badge counter updates
  6. Feature Teaser

    Funding, Partners, and Research Report

    “We raised $8 million to work with some of the best business development, strategy, and investing teams in biopharma — as well as the biotech founders building what comes next. To celebrate our launch, we mapped the Chinese biopharma pipeline. Every drug, deal, and trial is already there. But most importantly, how biotech and pharma companies should be positioning themselves in 2026 and beyond.”

    On screen
    Bison Ventures Lead Investor Daiichi-Sankyo Plus 3 Top-10 Pharma China Pipeline Analysis 18,000+ assets 330+ out-licensing deals 5 years of strategic trends
    Camera
    Split framing with side graphic overlays
    Motion
    Logos and slide stacks animating alongside presenter
  7. Call to Action

    CTA and Sleuth Logo Stinger

    “Comment Sleuth below and we'll send you free access.”

    On screen
    Comment Sleuth below and we'll send you free access. Sleuth
    Camera
    Cut to dark navy graphic outro card
    Motion
    Minimalist logo mark snap and typography fade

Related AI Agents Product Launches

Explore all AI Agents launches →
OpenAI
@OpenAI
AI Agents
@OpenAI
OpenAI@OpenAI
Gopuff
@gopuff
AI Agents
@gopuff
Gopuff@gopuff
Elon Musk
@elonmusk
AI Agents
@elonmusk
Elon Musk@elonmusk